Interestingly, levels of S1P (and all of the sphingoid bases) were not decreased in severe psoriasis following treatment with Etanercept, suggesting that circulating S1P is associated with severe disease pathology independent of the TNF-α pathway. Here, TNF is linked to psoriasis.